These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7022806)

  • 21. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological characterization of antibodies eluted from chronically rejected human renal allografts.
    Mohanakumar T; Waldrep JC; Phibbs M; Mendez-Picon G; Kaplan AM; Lee HM
    Transplantation; 1981 Jul; 32(1):61-6. PubMed ID: 7022799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports.
    Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E
    Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of renal endothelial antigens and donor-specific antibodies in allograft rejection.
    Evans PR; Trickett LP; Smith JL; MacIver AG; Tate D; Slapak M
    Transplant Proc; 1984 Oct; 16(5):1181. PubMed ID: 6385373
    [No Abstract]   [Full Text] [Related]  

  • 25. Intrarenal distribution of endothelial antigens recognized by antibodies from renal allograft recipients.
    Paul LC; van Es LA; Kalff MW; de Graeff J
    Transplant Proc; 1979 Mar; 11(1):427-30. PubMed ID: 377670
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential effects of immunosuppressive agents on mononuclear cells infiltrating human renal allografts.
    Cunningham PR; Gross U; Matthews C; Sash C; Thomas F; Thomas J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):194-5. PubMed ID: 2650105
    [No Abstract]   [Full Text] [Related]  

  • 27. Function and phenotypes of T lymphocytes cloned from human rejected grafts.
    Moreau JF; Bonneville M; Peyrat MA; Godard A; Jacques Y; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):401-2. PubMed ID: 3274793
    [No Abstract]   [Full Text] [Related]  

  • 28. Four patterns of human renal allograft rejection: a cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Transplant Proc; 1977 Mar; 9(1):37-42. PubMed ID: 325780
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 30. B-cell alloantibodies and clinical kidney transplantation.
    Myburgh JA; Smit JA; Maier G; Meyers AM
    S Afr J Surg; 1978 Mar; 16(1):5-10. PubMed ID: 362561
    [No Abstract]   [Full Text] [Related]  

  • 31. Double staining analysis of mononuclear cells infiltrating rejected kidneys: immunohistochemical investigation of rejection mechanisms.
    Takeda I; Horimi T; Okabayashi T; Nagae S; Kaneda M; Mukai K; Shimoyama H; Chono S; Orita K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):372-3. PubMed ID: 3079158
    [No Abstract]   [Full Text] [Related]  

  • 32. Phenotype and function of extrathymic cells invading rejecting renal allografts in the nude rat.
    Bolton EM; Gracie JA; Bradley JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):344-5. PubMed ID: 2650145
    [No Abstract]   [Full Text] [Related]  

  • 33. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ; Harmer AW; Koffman CG; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract]   [Full Text] [Related]  

  • 34. Specific human alloantibody produced by Epstein-Barr virus transformation of infiltrating cells from a rejected kidney graft.
    Finnemore AM; Horsburgh T; Mistry N; Bell PR
    Transplant Proc; 1990 Oct; 22(5):2288. PubMed ID: 2171168
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB; Ladefoged SD; Larsen S
    APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cells infiltrating rejected human kidney allograft: composition and in vitro functional capacities.
    Charpentier B; Lang P; Martin B; Fries D
    Transplant Proc; 1981 Mar; 13(1 Pt 1):84-9. PubMed ID: 7022912
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-staining analysis of mononuclear cells infiltrating rejected kidney.
    Takeda I; Horimi T; Okabayashi T; Kaneda M; Shimoyama H; Chohno S; Tanaka I; Miyake N; Orita K
    Transplant Proc; 1988 Apr; 20(2):211-3. PubMed ID: 3284043
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against renal endothelial alloantigens.
    Paul LC; Carpenter CB
    Transplant Proc; 1980 Sep; 12(3 Suppl 1):43-8. PubMed ID: 7001703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.